Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Kidney International

• Publication date

  2008-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ki.2008.102PMID 18354383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

  2007cited by this paper
• Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187))

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• An In-Depth Review of the Evidence Linking Dietary Salt Intake and Progression of Chronic Kidney Disease

  2006cited by this paper
• Standards of Medical Care in Diabetes: Response to Power

  2006cited by this paper
• Standards of medical care in diabetes.

  2005cited by this paper
• Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension

  2005cited by this paper
• Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

  2004cited by this paper
• Dietary Salt, Blood Pressure, and Microalbuminuria

  2004cited by this paper
• K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

  2004cited by this paper
• K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

  2004cited by this paper
• Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.

  2003cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease

  2002cited by this paper
• Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.

  2001cited by this paper
• Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

  2001cited by this paper
• The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

  2001cited by this paper
• Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

  2000cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications.

  1999cited by this paper
• Brain and atrial natriuretic peptides: a dual peptide system of potential importance in sodium balance and blood pressure regulation in patients with essential hypertension

  1994cited by this paper
• Microalbuminuria in treated hypertensive men at high risk of coronary disease

  1993cited by this paper
• Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

  1989cited by this paper
• Long-term captopril therapy at low doses reduces albumin excretion in patients with essential hypertension and no sign of renal impairment.

  1985cited by this paper
• Comparative studies: enalapril versus hydrochlorothiazide as first-step therapy for the treatment of primary hypertension.

  1984cited by this paper
• Nephrology Dialysis Transplantation the Blunting of the Antiproteinuric Efficacy of Ace Inhibition by High Sodium Intake Can Be Restored by Hydrochlorothiazide Patients and Methods

  year unknowncited by this paper

• Predicting chronic responses to calcium channel blockade with a virtual population of African Americans with hypertensive chronic kidney disease

  2024cites this paper
• Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial

  2024cites this paper
• Kidney function trajectories, associated factors, and outcomes in multiethnic Asian patients with type 2 diabetes

  2024cites this paper
• A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality.

  2023cites this paper
• Oral Combined Hydrochlorothiazide/Lisinopril Versus Nifedipine for Postpartum Hypertension: A Comparative-Effectiveness Pilot Randomized Controlled Trial.

  2023cites this paper
• Purification and characterization of angiotensin-converting enzyme (ACE) from sheep lung

  2021cites this paper
• Hypertension in diabetes care: emerging roles of recent hypoglycemic agents

  2021cites this paper
• Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling.

  2021cites this paper
• Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors

  2020cites this paper
• THE EFFECT OF CALCIUM CHANNEL Blockers ON moderate or severe ALBUMINURIA IN DIABETIC, HYPERTENSIVE PATIENTS: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.

  2020cites this paper
• Diabetic Kidney Disease

  2020cites this paper
• Blood Pressure Management in Diabetic Kidney Disease

  2020cites this paper
• Angiotensin Converting Enzyme (ACE): A Marker for Personalized Feedback on Dieting

  2020cites this paper
• Prevalence of Microvascular and Macrovascular Disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study Cohort.

  2020cites this paper
• Assessment of Kidney Status in Cardiac Children Treated with Angiotensin Converting Enzyme Inhibitors

  2019cites this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

  2019cites this paper
• Effect of amlodipine, efonidipine, and trichlormethiazide on home blood pressure and upper-normal microalbuminuria assessed by casual spot urine test in essential hypertensive patients

  2018cites this paper
• Antioxidant and Angiotensin I Converting Enzyme Inhibition Effects and Antihypertensive Effect in Spontaneously Hyertensive Rats of Peptide Isolated from Boiled Abalone By-Products, Hallotis discus hannai

  2018cites this paper
• 24 – Renin Angiotensin Aldosterone System Blockers

  2018cites this paper
• 33 – Hypertension and Chronic Kidney Disease

  2018cites this paper
• Amlodipine in the Era of New Generation Calcium Channel Blockers.

  2018cites this paper
• The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis

  2018cites this paper
• Antialbuminuric effect of eplerenone in comparison to thiazide diuretics in patients with hypertension

  2017cites this paper
• Blood pressure management in patients with type 2 diabetes mellitus

  2017cites this paper
• Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME

  2017cites this paper
• Dihydropyridine calcium channel blockers and renal disease

  2017cites this paper
• Olmesartan with azelnidipine versus with trichlormethiazide on home blood pressure variability in patients with type II diabetes mellitus.

  2017cites this paper
• Comparison between the effects of hydrochlorothiazide and indapamide on the kidney in hypertensive patients inadequately controlled with losartan

  2017cites this paper
• Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial

  2017cites this paper
• Antihypertensive and metabolic effects of hydrochlorothiazide versus amlodipine when added to losartan in patients with type 2 diabetes

  2016cites this paper
• The association between albuminuria and long-term renal risk: How to improve the precision of drug effect estimates

  2016cites this paper
• Effect of hydrochlorothiazide and spironolactone on reducing proteinuria among patients with diabetic nephropathy treated by angiotensin converting enzyme inhibitors

  2016influential citation
• Angiotensin System Blockade Combined With Calcium Channel Blockers Is Superior to Other Combinations in Cardiovascular Protection With Similar Blood Pressure Reduction: A Meta‐Analysis in 20,451 Hypertensive Patients

  2016cites this paper
• Importance of inhibiting sodium-glucose cotransporter and its compelling indication in type 2 diabetes: pathophysiological hypothesis.

  2016cites this paper
• Biochemical characterization of a novel antioxidant and angiotensin I-converting enzyme inhibitory peptide from Struthio camelus egg white protein hydrolysis

  2016cites this paper
• Renoprotective effects of renin–angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients

  2016influential citation
• Comparison of telmisartan/amlodipine and telmisartan/hydrochlorothiazide in the treatment of Japanese patients with uncontrolled hypertension: the TAT-Kobe study

  2016cites this paper
• Hypertension: Impact of blood pressure lowering in type 2 diabetes

  2015cites this paper
• Hypertension: Introduction, Types, Causes, and Complications

  2015cites this paper
• Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial

  2015cites this paper
• Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure and kidney function in hypertensive patients: a meta-analysis

  2015cites this paper
• Contributor to Systemic Hypertension Renin-Angiotensin System is the Dominant Counterpoint: Activation of the Intrarenal

  2015cites this paper
• A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication

  2015cites this paper
• Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min).

  2015cites this paper
• Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathy.

  2015cites this paper
• Visit-to-visit variability and seasonal variation in blood pressure: Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial subanalysis*

  2015cites this paper
• The effects of calcium channel blockers on nephropathy and pigment epithelium-derived factor in the treatment of hypertensive patients with type 2 diabetes mellitus

  2015cites this paper
• Management of Hypertension in Chronic Kidney Disease

  2015cites this paper
• Multifunctional L/N- and L/T-type calcium channel blockers for kidney protection

  2015cites this paper
• Bioactive Peptides from Meat Proteins as Functional Food Components

  2015cites this paper
• Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study

  2015cites this paper
• Influence of angiotensin II receptor blocker combination tablet prescription on drug number and cost

  2014cites this paper
• [Blood pressure goal and antihypertensive therapy in chronic kidney disease].

  2014cites this paper
• Type 2 diabetes mellitus complicated by hypertension in Japanese patients: switching treatment from high-dose angiotensin II receptor blockers to losartan plus hydrochlorothiazide.

  2014cites this paper
• Chapitre 11 – Néphropathie diabétique

  2014cites this paper
• Renin Angiotensin Aldosterone System (RAAS): its biology and drug targets for treating diabetic nephropathy.

  2014cites this paper
• Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension

  2014cites this paper
• Peter Andrew McCullough, MD, MPH: an interview with the editor.

  2014cites this paper
• Angiotensin receptor blocker (ARB)–diuretic versus ARB–calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy

  2014cites this paper
• Pharmacokinetics of Lipid-Lowering Medications in Chronic Kidney Disease

  2014cites this paper
• Clinical therapeutic strategies for early stage of diabetic kidney disease.

  2014cites this paper
• Cation-chloride cotransporters: Regulation, physiological significance, and role in pathogenesis of arterial hypertension

  2014cites this paper
• Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker?

  2013cites this paper
• Comparison of the Antialbuminuric Effects of L-/N-type and L-type Calcium Channel Blockers in Hypertensive Patients with Diabetes and Microalbuminuria: The Study of Assessment for Kidney Function by Urinary Microalbumin in Randomized (SAKURA) Trial

  2013cites this paper
• Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis

  2013cites this paper
• Targeting albuminuria in arterial hypertension and diabetes: how is it best achieved and what is its clinical relevance?

  2013cites this paper
• Prevention of Chronic Kidney Disease and Subsequent Effect on Mortality: A Systematic Review and Meta-Analysis

  2013cites this paper
• 2．慢性腎臓病（CKD）における高血圧治療―Na調節を中心に―

  2013cites this paper
• Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension.

  2013cites this paper
• Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial

  2013cites this paper
• Clinical Implications of the Change in Glomerular Filtration Rate with Adrenergic Blockers in Patients with Morning Hypertension: The Japan Morning Surge-1 Study

  2013cites this paper
• Angiotensin-converting enzyme inhibitors reduce albuminuria more than angiotensin receptor blockers in patients with type 2 diabetes.

  2013cites this paper
• Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.

  2013cites this paper
• Which is a Better Treatment for Hypertensive Patients with Diabetes: A Combination of Losartan and Hydrochlorothiazide or a Maximum Dose of Losartan?

  2013cites this paper
• Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: results after 1 year

  2013cites this paper
• Comparison of the Effect of Combination Therapy with an Angiotensin II Receptor Blocker and Either a Low-Dose Diuretic or Calcium Channel Blocker on Cardiac Hypertrophy in Patients with Hypertension

  2013cites this paper
• Comparison of spironolactone and trichlormethiazide as add‐on therapy to renin–angiotensin blockade for reduction of albuminuria in diabetic patients

  2013cites this paper
• Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan–diuretic

  2013cites this paper
• Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study.

  2013cites this paper
• [110th Scientific Meeting of the Japanese Society of Internal Medicine: Invited lecture: 2. Strategy for the treatment of hypertension in chronic kidney disease, focusing on Na regulation].

  2013cites this paper
• Therapeutic Modalities in Diabetic Nephropathy: Standard and Emerging Approaches

  2012cites this paper
• Optimal Combination of Effective ANtihypertensives (OCEAN) study: a prospective, randomized, open-label, blinded endpoint trial—rationale, design and results of a pilot study in Japan

  2012cites this paper
• Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial.

  2012cites this paper
• Diabetic nephropathy--the family physician's role.

  2012cites this paper
• NKCC1 and hypertension: Role in the regulation of vascular smooth muscle contractions and myogenic tone

  2012cites this paper
• Diabetes and the Kidney

  2012cites this paper
• Chronic kidney disease in the elderly - assessment and management.

  2012cites this paper
• Renal endpoints in renal and cardiovascular randomized clinical trials: time for a consensus?

  2012cites this paper
• Differential blood pressure reductions by angiotensin receptor blocker plus calcium channel blocker or diuretic in elderly hypertension with or without obesity.

  2012cites this paper
• Blood pressure in renal disease: how to accomplish the goal?

  2012cites this paper
• Management of Diabetic Nephropathy in the Elderly: Special Considerations.

  2012cites this paper
• Albuminuria-reducing effect of angiotensin II receptor blocker plus hydrochlorothiazide combination therapy in renal transplant recipients.

  2012influential citation
• Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study

  2012cites this paper
• Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.

  2012cites this paper
• Abordagem terapêutica da hipertensão arterial no doente diabético.

  2012cites this paper
• Differential effects of strict blood pressure lowering by losartan/hydrochlorothiazide combination therapy and high-dose amlodipine monotherapy on microalbuminuria: the ALPHABET study.

  2012influential citation
• Initial hypertension treatment: one combination fits most?

  2011cites this paper
• The efficacy and safety of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in chronic kidney disease, dialysis, and transplant patients.

  2011cites this paper
• Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials

  2011cites this paper
• [Optimization of the control of blood pressure. What contribution can be obtained from use of combinations of fixed doses of ace inhibitors and calcium channel blockers?].

  2011cites this paper